Realisation I 2024 Ltd
11692304
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 22/11/2018
CHIEF EXECUTIVE
SWEDISH · UNITED KINGDOM · Age 43
Also on 2 other boards
Persons with Significant Control
Cellen Life Sciences Limited
Cannon Place, 78 Cannon Street, London, EC4N 6AF
Reg: 12164338 · The Register Of Companies For England And Wales · Private Company Limited By Shares
Notified 27/08/2019
Former PSCs
Mr Eric Gustaf Bystrom
Ceased 27/08/2019
Dr Benjamin Marie Viaris De Lesegno
Ceased 27/08/2019
CompanyRankvs 15+ SIC 46460 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2023
Net Worth
-£1.9M
Balance sheet strength
Cash
£509k
Cash in the bank
Net Current Assets
£1.8M
Working capital
Current Assets
£2.0M
Current Liabilities
£128k
Fixed Assets
£205k
Debtors
£1.4M
Director Loans
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 15.20 | -£415k |
| 2022 | 1.67 | -£824k |
| 2021 | 3.79 | -£489k |
| 2020 | 5.40 | -£191k |
| 2019 | 9.90 | — |
Derived from filed accounts. Not audited figures.